1
|
Al-Aqbi ZT, Abdulsahib HT, Al-Doghachi FAJ. Micro/nanofluidic device for tamsulosin therapeutic drug monitoring in patients with benign prostatic hyperplasia at point of care. ANAL SCI 2024; 40:1101-1110. [PMID: 38468109 DOI: 10.1007/s44211-024-00533-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Accepted: 02/08/2024] [Indexed: 03/13/2024]
Abstract
Discovering the balance between toxicity and efficacy for many drugs requires therapeutic drug monitoring (TDM) of their concentrations in the blood. Here, a hot-embossed microfluidic device with a new design integrated to a nanofracture is presented for purification of blood samples from numerous proteins and cells, allowing to the separation of small molecules from blood matrix. The device was used to separate and quantitatively detect tamsulosin drug after derivatization with fluorescamine reagent, allowing converting it from a neutral molecule into a charged fluorescent complex under the experimental conditions, and thus its separation by electrophoresis. The device is portable and easy operated, and the presented method showed good linearity (R2 = 0.9948) over a concentration range of 0.1-1 μg/mL. The relative standard deviation (RSD%) was below 10% (n = 3), indicating good precisions, and the limit of detection (LOD) and limit of quantitation (LOQ) values were estimated to be 0.1 and 0.55 μg/mL, respectively. Whole blood samples from 10 patients with benign prostatic hyperplasia (BPH) were analyzed, showing good percentage recoveries of tamsulosin in whole blood. This point-of-care (POC), low-cost method could increase the convenience of patients and doctors, make therapies safer, and make TDM available in different regions and places.
Collapse
Affiliation(s)
- Zaidon T Al-Aqbi
- Department of Chemistry, Faculty of Science, University of Basrah, Basrah, 61004, Iraq.
- Department of Chemistry, College of Science, University of Misan, Maysan, 62001, Iraq.
| | - Hassan T Abdulsahib
- Department of Chemistry, Faculty of Science, University of Basrah, Basrah, 61004, Iraq
| | - Faris A J Al-Doghachi
- Department of Chemistry, Faculty of Science, University of Basrah, Basrah, 61004, Iraq
| |
Collapse
|
2
|
Luna R, Heineck D, Hinestrosa JP, Dobrovolskia I, Hamilton S, Malakian A, Gustafson KT, Huynh KT, Kim S, Ware J, Stimson E, Ross C, Schutt CE, Ibsen SD. Enhancement of dielectrophoresis-based particle collection from high conducting fluids due to partial electrode insulation. Electrophoresis 2023; 44:1234-1246. [PMID: 37431197 PMCID: PMC10656105 DOI: 10.1002/elps.202200295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 04/18/2023] [Accepted: 05/04/2023] [Indexed: 07/12/2023]
Abstract
Dielectrophoresis (DEP) is a successful method to recover nanoparticles from different types of fluid. The DEP force acting on these particles is created by an electrode microarray that produces a nonuniform electric field. To apply DEP to a highly conducting biological fluid, a protective hydrogel coating over the metal electrodes is required to create a barrier between the electrode and the fluid. This protects the electrodes, reduces the electrolysis of water, and allows the electric field to penetrate into the fluid sample. We observed that the protective hydrogel layer can separate from the electrode and form a closed domed structure and that collection of 100 nm polystyrene beads increased when this occurred. To better understand this collection increase, we used COMSOL Multiphysics software to model the electric field in the presence of the dome filled with different materials ranging from low-conducting gas to high conducting phosphate-buffered saline fluids. The results suggest that as the electrical conductivity of the material inside the dome is reduced, the whole dome acts as an insulator which increases electric field intensity at the electrode edge. This increased intensity widens the high-intensity electric field factor zone resulting in increased collection. This informs how dome formation results in increased particle collection and provides insight into how the electric field can be intensified to the increase collection of particles. These results have important applications for increasing the recovery of biologically-derived nanoparticles from undiluted physiological fluids that have high conductance, including the collection of cancer-derived extracellular vesicles from plasma for liquid biopsy applications.
Collapse
Affiliation(s)
- Ramona Luna
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Biological Dynamics, San Diego CA, USA
| | - Daniel Heineck
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
| | | | | | - Sean Hamilton
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Anna Malakian
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
| | - Kyle T. Gustafson
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Katherine T. Huynh
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Sejung Kim
- School of Chemical Engineering, Clean Energy Research Center, Jeonbuk National University, 567 Baekjedae-ro, Jeonju-si, Jeollabuk-do, 54896, South Korea
| | - Jason Ware
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Ella Stimson
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Christian Ross
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
| | - Carolyn E. Schutt
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| | - Stuart D. Ibsen
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, USA
- Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, USA
| |
Collapse
|
3
|
Nath P, Mahtaba KR, Ray A. Fluorescence-Based Portable Assays for Detection of Biological and Chemical Analytes. SENSORS (BASEL, SWITZERLAND) 2023; 23:s23115053. [PMID: 37299780 DOI: 10.3390/s23115053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/16/2023] [Accepted: 05/22/2023] [Indexed: 06/12/2023]
Abstract
Fluorescence-based detection techniques are part of an ever-expanding field and are widely used in biomedical and environmental research as a biosensing tool. These techniques have high sensitivity, selectivity, and a short response time, making them a valuable tool for developing bio-chemical assays. The endpoint of these assays is defined by changes in fluorescence signal, in terms of its intensity, lifetime, and/or shift in spectrum, which is monitored using readout devices such as microscopes, fluorometers, and cytometers. However, these devices are often bulky, expensive, and require supervision to operate, which makes them inaccessible in resource-limited settings. To address these issues, significant effort has been directed towards integrating fluorescence-based assays into miniature platforms based on papers, hydrogels, and microfluidic devices, and to couple these assays with portable readout devices like smartphones and wearable optical sensors, thereby enabling point-of-care detection of bio-chemical analytes. This review highlights some of the recently developed portable fluorescence-based assays by discussing the design of fluorescent sensor molecules, their sensing strategy, and the fabrication of point-of-care devices.
Collapse
Affiliation(s)
- Peuli Nath
- Department of Physics and Astronomy, University of Toledo, Toledo, OH 43606, USA
| | - Kazi Ridita Mahtaba
- Department of Physics and Astronomy, University of Toledo, Toledo, OH 43606, USA
| | - Aniruddha Ray
- Department of Physics and Astronomy, University of Toledo, Toledo, OH 43606, USA
| |
Collapse
|
6
|
Silva MLS. Microfluidic devices for glycobiomarker detection in cancer. Clin Chim Acta 2021; 521:229-243. [PMID: 34273337 DOI: 10.1016/j.cca.2021.07.013] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Revised: 07/07/2021] [Accepted: 07/12/2021] [Indexed: 12/20/2022]
Abstract
During oncogenesis, several alterations occur within cells, one of them being the abnormal glycosylation of proteins, resulting in the formation of glycoproteins with aberrant glycan structures, which can be secreted into the blood stream. Their specific association to tumour cells makes them useful indicators (biomarkers) of the oncogenic process and their detection in blood can be employed in different stages of tumour development for early detection, prognosis and therapeutic drug monitoring. Due to the importance of detecting cancer-associated glycoproteins with aberrant glycosylation in blood or serum, analytical methodologies with improved performance are required to ameliorate the laboratorial tests currently used for the detection of these analytes. Microfluidics was created to facilitate the implementation of simple and point-of-care analysis, away from a centralized laboratory. The massive use of microfluidic systems in clinical settings can be seen in pregnancy tests and diabetes control, for example. But what about other clinical domains, such as the detection of glycoproteins with aberrant glycans secreted by tumour cells? Are microfluidic systems helpful in this case? This review analyses the requirements of a microfluidic assay for the detection of low-abundant blood/serum cancer-associated glycoproteins with abnormal glycans and the progresses that have been made in the last years to develop integrated microfluidic devices for this particular application. The diverse microfluidic systems found in literature present, in general, the same analytical performance as the conventional assays but have additional advantages, namely a reduction in assay times, a decrease of sample and reagent consumption and lower costs. The review will also focus on the improvements that are still needed for better biosensing of this type of cancer biomarkers using microfluidic devices.
Collapse
Affiliation(s)
- M Luísa S Silva
- Centre of Chemical Research, Autonomous University of Hidalgo State, Carr. Pachuca-Tulancingo km 4.5, Pachuca, Hidalgo 42076, Mexico.
| |
Collapse
|